Liu; Wai

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liu; Wai.The latest application filed is for "method for determining efficacy".

Company Profile

7.6.17

Liu; Wai - London GB
LIU; Wai - Kent GB
LIU; Wai - Chestfield GB
Liu; Wai - Old Coulsdon GB
Liu; Wai - Sandwich GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Determining Efficacy App 20220196659 - Liu; Wai	2022-06-23
Method Of Monitoring Treatment App 20220177975 - Liu; Wai	2022-06-09
Cancer Treatment Comprising Naltrexone And A Cannabinoid App 20220143010 - Liu; Wai ; et al.	2022-05-12
Priming Of Cancer Cells With Low Dose Naltrexone App 20210308125 - Dalgleish; Angus ; et al.	2021-10-07
Combination Of Cannabinoids In The Treatment Of Leukaemia App 20210308072 - Wright; Stephen ; et al.	2021-10-07
Priming of cancer cells with low dose naltrexone Grant 11,065,245 - Dalgleish , et al. July 20, 2	2021-07-20
Combination of cannabinoids in the treatment of leukaemia Grant 11,000,486 - Wright , et al. May 11, 2	2021-05-11
Autoimmune Therapy App 20210052574 - Liu; Wai ; et al.	2021-02-25
Combination Of A Cannabinoid And A Chemotheraopeutic Agent For The Treatment Of Breast Cancer App 20210030779 - Dalgleish; Angus ; et al.	2021-02-04
Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumour Grant 10,758,514 - Liu , et al. Sep	2020-09-01
Combination Of Cannabinoids In The Treatment Of Leukaemia App 20200022925 - Wright; Stephen ; et al.	2020-01-23
Pyrimidine Compositions, Ultra-pure Compositions And Salts Thereof, Methods Of Making The Same, And Methods Of Using The Same For Treating Histamine H4 Receptor (h4) Mediated Diseases And Conditions App 20190135787 - ZHU; Zhijian ; et al.	2019-05-09
Use Of Tetrahydrocannabinol And/or Cannabidiol For Increasing Radiosensitivity In The Treatment Of A Brain Tumour App 20190099398 - LIU; Wai ; et al.	2019-04-04
Pyrimidine Compositions, Ultra Pure Compositions And Salts Thereof, Methods Of Making The Same, And Methods Of Using The Same For Treating Histamine H4 Receptor (h4) Mediated Diseases And Conditions App 20170158671 - ZHU; Zhijian ; et al.	2017-06-08
Priming Of Cancer Cells With Low Dose Naltrexone App 20170119755 - Dalgleish; Angus ; et al.	2017-05-04
Use Of Tetrahydrocannabinol And/or Cannabidiol For Increasing Radiosensitvity In The Treatment Of A Brain Tumour App 20160136127 - LIU; Wai ; et al.	2016-05-19
Methods of treating cancer using a combination of an immunomodulatory compound and an artemisinin or a derivative thereof Grant 9,226,913 - Dalgleish , et al. January 5, 2	2016-01-05
Methods Of Treating Cancer Using A Combination Of An Immunomodulatory Compound And An Artemisinin Or A Derivative Thereof App 20130136757 - Dalgleish; Angus ; et al.	2013-05-30
ANTI IgE ANTIBODIES App 20110064726 - Liu; Wai ; et al.	2011-03-17
Anti-IgE antibodies Grant 7,867,494 - Liu , et al. January 11, 2	2011-01-11
Anti-IgE antibodies App 20090117124 - Liu; Wai ; et al.	2009-05-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.